Ocular Melanoma clinical trials

Explore recruiting ocular melanoma clinical trials.

Recruiting ocular melanoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ocular Melanoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

(Neo)adjuvant IDE196 (Darovasertib) in Patients with Localized Ocular Melanoma

Italy, France, Netherlands, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase II, Multi-centre, Open label, Randomised Study to Evaluate the Anti-tumour Activity of Roginolisib (IOA-244) in Patients with Advanced/Metastatic Ocular/Uveal Melanoma

Italy, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Ocular Melanoma trials by city

Ocular Melanoma in Toronto Ocular Melanoma in Vancouver Ocular Melanoma in Montreal Ocular Melanoma in Calgary Ocular Melanoma in Edmonton Ocular Melanoma in Ottawa Ocular Melanoma in Winnipeg Ocular Melanoma in Quebec City Ocular Melanoma in Hamilton Ocular Melanoma in Kitchener Ocular Melanoma in London Ocular Melanoma in Halifax Ocular Melanoma in New York Ocular Melanoma in Los Angeles Ocular Melanoma in Chicago Ocular Melanoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease